Medical oncology laboratory (VUmc)

Research output

Research output per year 1989 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 1256 Article
• 153 Review article
• 43 Chapter
• 30 Comment/Letter to the editor
• 98 More
  • 27 Meeting Abstract
  • 23 Editorial
  • 15 Phd-Thesis - Research and graduation internal
  • 13 Letter
  • 5 Poster
  • 4 Erratum/Corrigendum
  • 3 Report
  • 3 Patent
  • 2 Inaugural speech
  • 1 Conference contribution
  • 1 Short survey
  • 1 Phd-Thesis - Research and graduation external

Research output per year

Research output per year

Search results

• 2024

  Clinical Proteomics: A Promise Becoming Reality

  Gillette, M. A., Jimenez, C. R. & Carr, S. A., 1 Feb 2024, In: Molecular and Cellular Proteomics. 23, 2, 100688.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access

• Revolutionizing Cancer Treatment: Unveiling New Frontiers by Targeting the (Un)Usual Suspects

  Costa, V., Giovannetti, E. & Lonardo, E., 1 Jan 2024, In: Cancers. 16, 1, 132.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
• 2023

  Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

  Cavallari, I., Cerciello, F., Giovannetti, E. & Urso, L., 2023, In: Frontiers in Oncology. 13, 1163144.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access

• Extracellular vesicles in cancer: Shaping the intricate network of metabolic reprogramming and immune interactions in the tumor microenvironment

  Giovannetti, E. & Li, T., Oct 2023, In: Cytokine & Growth Factor Reviews. 73, p. 1-2 2 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

• Rising impact of cell death research

  Nowak-Sliwinska, P. & Griffioen, A. W., Dec 2023, In: Apoptosis. 28, 11-12, p. 1503-1504 2 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  1 Citation (Scopus)
• 2022

  Biofilm Formation as Valuable Target to Fight against Severe Chronic Infections

  Pecoraro, C., Carbone, D., Deng, D., Cascioferro, S. M., Diana, P. & Giovannetti, E., 2022, In: Current medicinal chemistry. 29, 25, p. 4307-4310 4 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  22 Citations (Scopus)

• Editorial: Women in pharmacology of anti-cancer drugs: 2021

  Giovannetti, E., 30 Nov 2022, In: Frontiers in Pharmacology. 13, 1092204.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access

• Novel Strategies to Address Critical Challenges in Pancreatic Cancer

  Puik, J. R., Swijnenburg, R-J., Kazemier, G. & Giovannetti, E., 1 Sept 2022, In: Cancers. 14, 17, 4115.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Programmed cell death lives

  Griffioen, A. W. & Nowak-Sliwinska, P., Oct 2022, In: Apoptosis. 27, 9-10, p. 619-621 3 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  5 Citations (Scopus)

• The rising impact of angiogenesis research

  Griffioen, A. W. & Dudley, A. C., Nov 2022, In: Angiogenesis. 25, 4, p. 435-437 3 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  9 Citations (Scopus)
• 2020

  Immune checkpoint inhibition: from molecules to clinical application

  Taams, L. S. & de Gruijl, T. D., 1 May 2020, In: Clinical and experimental immunology. 200, 2, p. 105-107 3 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• NUC-1031 in biliary tract cancer: from bench to bedside and back?

  Boyd, L. N. C., Peters, G. J., Kazemier, G. & Giovannetti, E., 1 Jun 2020, In: Cancer Chemotherapy and Pharmacology. 85, 6, p. 1011-1014 4 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  3 Citations (Scopus)

• Programmed death, cells on the last train to glory

  Nowak-Sliwinska, P. & Griffioen, A. W., 1 Apr 2020, In: Apoptosis. 25, 3-4, p. 151-153 3 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  3 Citations (Scopus)
• 2019

  Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?

  Liu, D. S. K., Mato Prado, M., Giovannetti, E., Jiao, L. R., Krell, J. & Frampton, A. E., 3 Jul 2019, In: Expert review of molecular diagnostics. 19, 7, p. 553-558 6 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  1 Citation (Scopus)

• Cell death rocks

  Griffioen, A. W. & Nowak-Sliwinska, P., 15 Apr 2019, In: Apoptosis. 24, p. 205–207

  Research output: Contribution to journal › Editorial › Academic › peer-review
  3 Citations (Scopus)
• 2018

  Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks: new wine deserves new sacks

  van Meerbeeck, J. P., Jansen, G., Giovannetti, E. & Peters, G. J., 2018, In: European respiratory journal. 51, 5, p. pii: 1800807 4 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review

• Apoptosis on the move

  Nowak-Sliwinska, P. & Griffioen, A. W., 2018, In: Apoptosis. 23, 5-6, p. 251-254

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access
  7 Citations (Scopus)

• Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients

  Santarpia, M., Funel, N., Ali, A. & Giovannetti, E., 2018, In: Expert Opinion on Drug Metabolism and Toxicology. 14, 8, p. 761-763 3 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  1 Citation (Scopus)

• Personalized medicine in rheumatoid arthritis: methotrexate polyglutamylation revisited

  Muller, I. B., Hebing, R. F., Jansen, G., Nurmohamed, M. T., Lems, W. F., Peters, G. J. & de Jonge, R., 2018, In: Expert Review of Precision Medicine and Drug Development. 3, 6, p. 331-334 4 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  10 Citations (Scopus)
• 2017

  Angiogenesis inhibitors in combinatorial approaches

  Nowak-Sliwinska, P. & Griffioen, A. W., 1 May 2017, In: Angiogenesis. 20, 2, p. 183-184 2 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  6 Citations (Scopus)

• Apoptosis turns 21

  Griffioen, A. W. & Nowak-Sliwinska, P., 1 Dec 2017, In: Apoptosis. 22, 12, p. 1485-1486 2 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  6 Citations (Scopus)

• Should alectinib or ceritinib be given as first line therapy for ALK positive non-small cell lung cancer patients instead of crizotinib?

  Peters, G. J., Muller, I. B. & Giovannetti, E., 1 Aug 2017, In: Translational Cancer Research. 6, p. S1010-S1013

  Research output: Contribution to journal › Editorial › Academic › peer-review
  2 Citations (Scopus)
• 2001

  Folate homeostasis and antiproliferative activity of folates and antifolates

  Peters, G. J. & Jansen, G., 2001, In: Nutrition. 17, 9, p. 737-738 2 p.

  Research output: Contribution to journal › Editorial › Academic › peer-review
  11 Citations (Scopus)